Aligos Therapeutics (ALGS) announced the appointment of Laura Kavanaugh, JD as Vice President, Head of Legal, effective immediately. Most recently, she served as Vice President, Corporate Law & Privacy Officer at Codexis (CDXS).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Aligos Therapeutics presents data at EASL Congress 2025
- Aligos Therapeutics Reports Strong Q1 2025 Progress
- Aligos Therapeutics reports Q1 EPS ($2.11), consensus ($3.15)
- UPS downgraded, ServiceNow upgraded: Wall Street’s top analyst calls